VYNE Therapeutics Investors

30 investors on Angel Roster list VYNE Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, China and Taiwan.

Investors are matched on the company name in their portfolio, so companies that share the name VYNE Therapeutics can appear together.

Investors listed
30
With verified email
53%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 30 VYNE Therapeutics investors

The most complete profiles first. Showing 30 of 30.

  • Albert ChaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 81 more

    Verified email available

  • Mahendra ShahVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Nathan DauVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Richard GasterVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Verified email available

  • Sunny ReddyVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Adam WilczekVerified

    Venture Capital · United States

    Health CareTelecommunicationsCybersecurityWomen Founded

    Portfolio: Neos Therapeutics, Nominum, Mojo Networks, Ensim Corporation and 8 more

    Verified email available

  • Aftab KheraniVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Andrew SchiffVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 60 more

    Verified email available

  • David BeierVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Verified email available

  • David CollierVerified

    Venture Capital · United States

    Health CareTelecommunicationsCybersecurityWomen Founded

    Portfolio: Neos Therapeutics, Nominum, Mojo Networks, Ensim Corporation and 8 more

    Verified email available

  • David PezeshkiVerified

    Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Verified email available

  • Eric AguiarVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Jim WatsonVerified

    Venture Capital, Private Equity Firm · United States

    Health CareTelecommunicationsCybersecurityWomen Founded

    Portfolio: Neos Therapeutics, Nominum, Mojo Networks, Ensim Corporation and 8 more

    Verified email available

  • Josh BilenkerVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Qi ZhuVerified

    Venture Capital, Private Equity Firm · China

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Robert WenzelVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Aaron Royston, M.D.

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, HistoWiz and 35 more

    Contact details available

  • Frank Kung

    Venture Capital, Founder, Private Equity Firm · United States

    Series BHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 76 more

    Contact details available

  • Jaume Pons

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Contact details available

  • Yvonne Yamanaka

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Contact details available

  • Andrew Goldberg

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Dayton Misfeldt

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Fred Craves

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Matt Kronmiller

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Nina Feng

    Venture Capital, Private Equity Firm · Taiwan

    Health CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Peter Gajdos

    Venture Capital · United States

    Health CareTelecommunicationsCybersecurityWomen Founded

    Portfolio: Neos Therapeutics, Nominum, Mojo Networks, Ensim Corporation and 8 more

    Contact details available

  • Scott Braunstein

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Contact details available

  • Shan Fu

    Venture Capital, Private Equity Firm · China

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Sophie Phillips

    Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Contact details available

  • carl goldfischer

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

Frequently asked questions

How many VYNE Therapeutics investors are on Angel Roster?

Angel Roster lists 30 VYNE Therapeutics investors. 16 of them (53%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (28), Private Equity Firms (22) and Founder-Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do VYNE Therapeutics investors invest in?

Among those that list a stage, the most common are Series B (7) and Seed (2).

Where are VYNE Therapeutics investors based?

Most are based in the United States (27), China (2) and Taiwan (1).

Which companies have VYNE Therapeutics investors backed?

The most-backed portfolio companies among them are Elevation Oncology (21), Verona Pharma (16), Bristol-Myers Squibb (16), Aclaris Therapeutics (16) and Poseida Therapeutics (16).

How do I contact VYNE Therapeutics investors?

Create a free Angel Roster account to search and filter all 30, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.